Related Experiment Videos
Management of post-cricoid carcinoma
Clinical Otolaryngology and Allied Sciences
|June 1, 1982
Summary
Radiotherapy is recommended for early-stage post-cricoid carcinoma, offering a 35% 5-year survival. Surgery for advanced or recurrent disease yields lower survival rates and higher complication risks.
Area of Science:
- Oncology
- Otorhinolaryngology
- Head and Neck Surgery
Background:
- Post-cricoid carcinoma is a rare but aggressive malignancy.
- Treatment strategies significantly impact patient outcomes and quality of life.
Purpose of the Study:
- To evaluate treatment outcomes for post-cricoid carcinoma.
- To compare the efficacy of radiotherapy versus surgery.
Main Methods:
- Retrospective analysis of 141 patients with post-cricoid carcinoma.
- Assessment of treatment modalities including radiotherapy and surgery.
- Evaluation of 5-year survival rates and complication incidence.
Main Results:
- Radiotherapy for small tumors without lymph node metastasis yielded a 35% 5-year survival.
- Surgery for larger or metastatic tumors resulted in a 20% 5-year survival with high complication rates.
- Salvage surgery after radiotherapy had limited success and significant complications.
Conclusions:
- Early-stage post-cricoid carcinoma without metastasis is best treated with radiotherapy.
- Surgery for advanced disease or recurrence is associated with poor outcomes and complications.
- Pharyngeal reconstruction after pharyngolaryngectomy shows no superior method among current techniques.